Mushroom polysaccharides from Ganoderma lucidum and Poria cocos reveal prebiotic functions

Journal of Functional Foods

Volumn 41, Issue , 2018, Pages 191-201

  Khan, Imran ^a   Huang, Guoxin ^a   Li, Xiaoang ^a   Leong, Waikit ^a   Xia, Wenrui ^a   Hsiao, W L Wendy ^a  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

16S amplicon sequencing; C57BL 6J mice; Ganoderma lucidum; Gut microbiota; Polysaccharides; Poria cocos

Indexed keywords

EID: 85042230863     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2017.12.046     Document Type: Article

References (79)

1. Al-Sheraji, S.H., Ismail, A., Manap, M.Y., Mustafa, S., Yusof, R.M., Hassan, F.A., Prebiotics as functional foods: A review. Journal of Functional Foods 5:4 (2013), 1542–1553, 10.1016/j.jff.2013.08.009.
2. Azmi, A.F.M.N., Mustafa, S., Hashim, D.M., Manap, Y.A., Prebiotic activity of polysaccharides extracted from Gigantochloa levis (Buluh beting) shoots. Molecules (Basel, Switzerland) 17:2 (2012), 1635–1651, 10.3390/molecules17021635.
3. Bahr, S.M., Weidemann, B.J., Castro, A.N., Walsh, J.W., deLeon, O., Burnett, C.M.L., Kirby, J.R., Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine 2:11 (2015), 1725–1734, 10.1016/j.ebiom.2015.10.018.
4. Bishop, K.S., Kao, C.H.J., Xu, Y., Glucina, M.P., Paterson, R.R.M., Ferguson, L.R., From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry 114 (2015), 56–65, 10.1016/j.phytochem.2015.02.015.
5. Boissiere, A., Tchioffo, M.T., Bachar, D., Abate, L., Marie, A., Nsango, S.E., Morlais, I., Midgut microbiota of the malaria mosquito vector Anopheles gambiae and interactions with Plasmodium falciparum infection. PLoS Pathogens, 8(5), 2012, e1002742, 10.1371/journal.ppat.1002742.
6. Brook, I., Fusobacterial infections in children. Journal of Infection 28:2 (1994), 155–165, 10.1016/S0163-4453(94)95600-6.
7. Brown, G.D., Gordon, S., Fungal beta-glucans and mammalian immunity. Immunity 19:3 (2003), 311–315, 10.1016/S1074-7613(03)00233-4.
8. Bui, T.P.N., deVos, W.M., Plugge, C.M., Anaerostipes rhamnosivorans sp. nov., a human intestinal, butyrate-forming bacterium. International Journal of Systematic and Evolutionary Microbiology 64:Pt3 (2014), 787–793, 10.1099/ijs.0.055061-0.
9. Castillo, N.A., DeMorenode LeBlanc, A., deMoreno de LeBlanc, A.M., Galdeano, C., Perdigón, G., Comparative study of the protective capacity against Salmonella infection between probiotic and nonprobiotic Lactobacilli. Journal of Applied Microbiology, 114, 2013, 10.1111/jam.12074.
10. Centanni, M., Hutchison, J.C., Carnachan, S.M., Daines, A.M., Kelly, W.J., Tannock, G.W., Sims, I.M., Differential growth of bowel commensal Bacteroides species on plant xylans of differing structural complexity. Carbohydrate Polymers 157 (2017), 1374–1382, 10.1016/j.carbpol.2016.11.017.
11. Chakdar, H., Kumar, M., Pandiyan, K., Singh, A., Nanjappan, K., Kashyap, P.L., Srivastava, A.K., Bacterial xylanases: Biology to biotechnology. 3 Biotech, 6(2), 2016, 150, 10.1007/s13205-016-0457-z.
12. Chalvatzi, S., Kalamaki, M.S., Arsenos, G., Fortomaris, P., Dietary supplementation with the clay mineral palygorskite affects performance and beneficially modulates caecal microbiota in laying pullets. Journal of Applied Microbiology 120:4 (2016), 1033–1040, 10.1111/jam.13041.
13. Chang, C.-J., Lin, C.-S., Lu, C.-C., Martel, J., Ko, Y.-F., Ojcius, D.M., Lai, H.-C., Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature Communications, 6, 2015, 7489, 10.1038/ncomms8489.
14. Chen, L., Tai, W., Hsiao, W., Dietary saponins from four popular herbal tea exert prebiotic-like effects on gut microbiota in C57BL/6 mice. Journal of Functional Foods 17 (2015), 892–902.
15. Chen, S., Xu, J., Liu, C., Zhu, Y., Nelson, D.R., Zhou, S., Sun, C., Genome sequence of the model medicinal mushroom Ganoderma lucidum. Nature Communications, 3, 2012, 913, 10.1038/ncomms1923.
16. Chou, W.-T., Sheih, I.-C., Fang, T.J., The applications of polysaccharides from various mushroom wastes as prebiotics in different systems. Journal of Food Science 78:7 (2013), M1041–8, 10.1111/1750-3841.12160.
17. Chumpitazi, B.P., Cope, J.L., Hollister, E.B., Tsai, C.M., McMeans, A.R., Luna, R.A., Shulman, R.J., Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 42:4 (2015), 418–427, 10.1111/apt.13286.
18. Daillere, R., Vetizou, M., Waldschmitt, N., Yamazaki, T., Isnard, C., Poirier-Colame, V., Zitvogel, L., Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity 45:4 (2016), 931–943, 10.1016/j.immuni.2016.09.009.
19. Dao, M.C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E.O., Clement, K., Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology. Gut 65:3 (2016), 426–436, 10.1136/gutjnl-2014-308778.
20. Davis, C.D., Milner, J.A., Gastrointestinal microflora, food components and colon cancer prevention. The Journal of Nutritional Biochemistry 20:10 (2009), 743–752, 10.1016/j.jnutbio.2009.06.001.
21. DeFilippo, C., Cavalieri, D., DiPaola, M., Ramazzotti, M., Poullet, J.B., Massart, S., Lionetti, P., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences 107:33 (2010), 14691–14696.
22. Derikx, L.A.A.P., Dieleman, L.A., Hoentjen, F., Probiotics and prebiotics in ulcerative colitis. Best Practice & Research. Clinical Gastroenterology 30:1 (2016), 55–71, 10.1016/j.bpg.2016.02.005.
23. Devillé C., Gharbi, M., Dandrifosse, G., Peulen, O., Study on the effects of laminarin, a polysaccharide from seaweed, on gut characteristics. Journal of the Science of Food and Agriculture 87:9 (2007), 1717–1725, 10.1002/jsfa.2901.
24. deVos, W.M., Microbe profile: Akkermansia muciniphila: A conserved intestinal symbiont that acts as the gatekeeper of our mucosa. Microbiology (Reading, England) 163:5 (2017), 646–648, 10.1099/mic.0.000444.
25. Dowd, S.E., Sun, Y., Wolcott, R.D., Domingo, A., Carroll, J.a., Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: Bacterial diversity in the ileum of newly weaned Salmonella-infected pigs. Foodborne Pathogens and Disease 5:4 (2008), 459–472, 10.1089/fpd.2008.0107.
26. DuToit, G., Lack, G., Can food allergy be prevented? The current evidence. Pediatric Clinics of North America 58:2 (2011), 481–509, 10.1016/j.pcl.2011.02.002 xii.
27. Eales, J., Gibson, P., Whorwell, P., Kellow, J., Yellowlees, A., Perry, R.H.J., Glanville, J., Systematic review and meta-analysis: The effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therapeutic Advances in Gastroenterology 10:1 (2017), 74–88, 10.1177/1756283X16670075.
28. Eren, A.M., Zozaya, M., Taylor, C.M., Dowd, S.E., Martin, D.H., Ferris, M.J., Exploring the diversity of gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS ONE, 6(10), 2011, 10.1371/journal.pone.0026732.
29. Flint, H.J., Scott, K.P., Duncan, S.H., Louis, P., Forano, E., Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3:4 (2012), 289–306, 10.4161/gmic.19897.
30. Fujimura, K.E., Slusher, N.A., Cabana, M.D., Lynch, S.V., Role of the gut microbiota in defining human health. Expert Review of Anti-Infective Therapy 8:4 (2010), 435–454, 10.1586/eri.10.14.
31. Fujio-Vejar, S., Vasquez, Y., Morales, P., Magne, F., Vera-Wolf, P., Ugalde, J.A., Gotteland, M., The gut microbiota of healthy Chilean subjects reveals a high abundance of the phylum verrucomicrobia. Frontiers in Microbiology, 8, 2017, 1221, 10.3389/fmicb.2017.01221.
32. Giavasis, I., Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals. Current Opinion in Biotechnology 26 (2014), 162–173, 10.1016/j.copbio.2014.01.010.
33. Gibson, G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J., Reid, G., Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews. Gastroenterology & Hepatology 14:8 (2017), 491–502, 10.1038/nrgastro.2017.75.
34. Guinane, C.M., Cotter, P.D., Role of the gut microbiota in health and chronic gastrointestinal disease: Understanding a hidden metabolic organ. Therapeutic Advances in Gastroenterology 6:4 (2013), 295–308, 10.1177/1756283X13482996.
35. Halfvarson, J., Brislawn, C.J., Lamendella, R., Vazquez-Baeza, Y., Walters, W.A., Bramer, L.M., Jansson, J.K., Dynamics of the human gut microbiome in inflammatory bowel disease. Nature Microbiology, 2, 2017, 17004, 10.1038/nmicrobiol.2017.4.
36. Hatziioanou, D., Mayer, M.J., Duncan, S.H., Flint, H.J., Narbad, A., A representative of the dominant human colonic Firmicutes, Roseburia faecis M72/1, forms a novel bacteriocin-like substance. Anaerobe 23 (2013), 5–8, 10.1016/j.anaerobe.2013.07.006.
37. Hiippala, K., Kainulainen, V., Kalliomaki, M., Arkkila, P., Satokari, R., Mucosal prevalence and interactions with the epithelium indicate commensalism of Sutterella spp. Frontiers in Microbiology, 7, 2016, 1706, 10.3389/fmicb.2016.01706.
38. Holscher, H.D., Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8:2 (2017), 172–184, 10.1080/19490976.2017.1290756.
39. Hove, H., Norgaard, H., Mortensen, P.B., Lactic acid bacteria and the human gastrointestinal tract. European Journal of Clinical Nutrition 53:5 (1999), 339–350.
40. Hsiao, W.L.W., Li, Y.Q., Lee, T.L., Li, N., You, M.M., Chang, S., Medicinal mushroom extracts inhibit ras-induced cell transformation and the inhibitory effect requires the presence of normal cells. Carcinogenesis 25:7 (2004), 1177–1183, 10.1093/carcin/bgh119.
41. Kullberg, M.C., Ward, J.M., Gorelick, P.L., Caspar, P., Hieny, S., Cheever, A., Sher, A., Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infection and Immunity 66:11 (1998), 5157–5166.
42. Lammerts van Bueren, A., Mulder, M., Leeuwen, S. van, Dijkhuizen, L., Prebiotic galactooligosaccharides activate mucin and pectic galactan utilization pathways in the human gut symbiont Bacteroides thetaiotaomicron. Scientific Reports, 7, 2017, 40478, 10.1038/srep40478.
43. Li, M., Li, G., Shang, Q., Chen, X., Liu, W., Pi, X., Wang, X., In vitro fermentation of alginate and its derivatives by human gut microbiota. Anaerobe 39 (2016), 19–25, 10.1016/j.anaerobe.2016.02.003.
44. Liu, Z., Chen, Z., Guo, H., He, D., Zhao, H., Wang, Z., Ni, L., The modulatory effect of infusions of green tea, oolong tea, and black tea on gut microbiota in high-fat-induced obese mice. Food & Function 7:12 (2016), 4869–4879, 10.1039/c6fo01439a.
45. Luerce, T.D., Gomes-Santos, A.C., Rocha, C.S., Moreira, T.G., Cruz, D.N., Lemos, L., Miyoshi, A., Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis. Gut Pathogens, 6(1), 2014, 33, 10.1186/1757-4749-6-33.
46. Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., Rodriguez Yoldi, M.J., Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. International Journal of Molecular Sciences, 18(1), 2017, 197, 10.3390/ijms18010197.
47. Masella, A.P., Bartram, A.K., Truszkowski, J.M., Brown, D.G., Neufeld, J.D., PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics 13:1 (2012), 1–7, 10.1186/1471-2105-13-31.
48. Mayo, B., vanSinderen, D., Ventura, M., Genome analysis of food grade lactic Acid-producing bacteria: From basics to applications. Current Genomics 9:3 (2008), 169–183, 10.2174/138920208784340731.
49. Meimandipour, A., Shuhaimi, M., Soleimani, A.F., Azhar, K., Hair-Bejo, M., Kabeir, B.M., Yazid, A.M., Selected microbial groups and short-chain fatty acids profile in a simulated chicken cecum supplemented with two strains of Lactobacillus. Poultry Science 89:3 (2010), 470–476, 10.3382/ps.2009-00495.
50. Mizuno, T., Saito, H., Nishitoba, T., KaWagishi, H., Antitumor-active substances from mushrooms. Food Reviews International 11:1 (1995), 23–61, 10.1080/87559129509541018.
51. Neyrinck, A.M., Possemiers, S., Verstraete, W., De Backer, F., Cani, P.D., Delzenne, N.M., Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. The Journal of Nutritional Biochemistry 23:1 (2012), 51–59, 10.1016/j.jnutbio.2010.10.008.
52. Oliveira, L.F.F., Salvador, S.L., Silva, P.H.F., Furlaneto, F.A.C., Figueiredo, L., Casarin, R., Messora, M.R., Benefits of Bifidobacterium animalis subsp. lactis Probiotic in experimental periodontitis. Journal of Periodontology 88:2 (2017), 197–208, 10.1902/jop.2016.160217.
53. Parvez, S., Malik, K.A., Ah Kang, S., Kim, H., Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology 100:6 (2006), 1171–1185.
54. Pfefferle, P.I., Prescott, S.L., Kopp, M., Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates. The Journal of Allergy and Clinical Immunology 131:6 (2013), 1453–1463, 10.1016/j.jaci.2013.03.020 quiz 1464.
55. Plaza-Diaz, J., Ruiz-Ojeda, F.J., Vilchez-Padial, L.M., Gil, A., Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients, 9(6), 2017, 10.3390/nu9060555.
56. Qamar, T.R., Syed, F., Nasir, M., Rehman, H., Zahid, M.N., Liu, R.H., Iqbal, S., Novel combination of prebiotics galacto-oligosaccharides and inulin-inhibited aberrant crypt foci formation and biomarkers of colon cancer in wistar rats. Nutrients, 8(8), 2016, 10.3390/nu8080465.
57. Riedel, C.U., Foata, F., Philippe, D., Adolfsson, O., Eikmanns, B.J., Blum, S., Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World Journal of Gastroenterology, 12, 2006.
58. Rios-Covian, D., Ruas-Madiedo, P., Margolles, A., Gueimonde, M., deLos Reyes-Gavilan, C.G., Salazar, N., Intestinal short chain fatty acids and their link with diet and human health. Frontiers in Microbiology, 7, 2016, 185, 10.3389/fmicb.2016.00185.
59. Ruengsomwong, S., La-Ongkham, O., Jiang, J., Wannissorn, B., Nakayama, J., Nitisinprasert, S., Microbial community of healthy Thai vegetarians and non-vegetarians, their core gut microbiota, and pathogen risk. Journal of Microbiology and Biotechnology 26:10 (2016), 1723–1735, 10.4014/jmb.1603.03057.
60. Scott, K.P., Antoine, J.-M., Midtvedt, T., vanHemert, S., Manipulating the gut microbiota to maintain health and treat disease. Microbial Ecology in Health and Disease, 26, 2015.
61. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., Metagenomic biomarker discovery and explanation. Genome Biology, 12(6), 2011, R60, 10.1186/gb-2011-12-6-r60.
62. Shen, D., Chen, R., Ye, L., Luo, Y., Tang, Y.-W., Robinsoniella peoriensis bacteremia in a patient with pancreatic cancer. Journal of Clinical Microbiology 48:9 (2010), 3448–3450, 10.1128/JCM.00477-10.
63. Shen, W., Shen, M., Zhao, X., Zhu, H., Yang, Y., Lu, S., Le, S., Anti-obesity effect of capsaicin in mice fed with high-fat diet is associated with an increase in population of the gut bacterium Akkermansia muciniphila. Frontiers in Microbiology, 8, 2017, 272, 10.3389/fmicb.2017.00272.
64. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., Garrett, W.S., The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (New York, N.Y.) 341:6145 (2013), 569–573, 10.1126/science.1241165.
65. Sun, Y., Biological activities and potential health benefits of polysaccharides from Poria cocos and their derivatives. International Journal of Biological Macromolecules 68 (2014), 131–134, 10.1016/j.ijbiomac.2014.04.010.
66. Swanson, K.S., Dowd, S.E., Suchodolski, J.S., Middelbos, I.S., Vester, B.M., Barry, K.A., Fahey, G.C., Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice. The ISME Journal 5:4 (2011), 639–649, 10.1038/ismej.2010.162.
67. Takahashi, K., Nishida, A., Fujimoto, T., Fujii, M., Shioya, M., Imaeda, H., Andoh, A., Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn's disease. Digestion 93:1 (2016), 59–65, 10.1159/000441768.
68. Taylor, N.S., Xu, S., Nambiar, P., Dewhirst, F.E., Fox, J.G., Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America. Journal of Clinical Microbiology 45:7 (2007), 2166–2172, 10.1128/JCM.00137-07.
69. Turnbaugh, P.J., Ley, R.E., Mahowald, M.a., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:7122 (2006), 1027–1031, 10.1038/nature05414.
70. Ubeda, C., Bucci, V., Caballero, S., Djukovic, A., Toussaint, N.C., Equinda, M., Pamer, E.G., Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infection and Immunology 81:3 (2013), 965–973, 10.1128/IAI.01197-12.
71. Vigsnaes, L.K., van denAbbeele, P., Sulek, K., Frandsen, H.L., Steenholdt, C., Brynskov, J., Licht, T.R., Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus. Scientific Reports, 3, 2013, 1110, 10.1038/srep01110.
72. Vital, M., Penton, C.R., Wang, Q., Young, V.B., Antonopoulos, D.A., Sogin, M.L., Tiedje, J.M., A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome, 1(1), 2013, 8, 10.1186/2049-2618-1-8.
73. Wang, N., Zhang, Y., Wang, X., Huang, X., Fei, Y., Yu, Y., Shou, D., Antioxidant property of water-soluble polysaccharides from Poria cocos Wolf using different extraction methods. International Journal of Biological Macromolecules 83 (2016), 103–110, 10.1016/j.ijbiomac.2015.11.032.
74. Wu, C. (2013). Human microbiome, actinobacteria. In K. E. Nelson (Ed.), Encyclopedia of metagenomics (pp. 1–7). New York, NY: Springer. http://doi.org/10.1007/978-1-4614-6418-1_76-9.
75. Xie, G., Wang, X., Liu, P., Wei, R., Chen, W., Rajani, C., Jia, W., Distinctly altered gut microbiota in the progression of liver disease. Oncotarget 7:15 (2016), 19355–19366, 10.18632/oncotarget.8466.
76. Xu, Z., Chen, X., Zhong, Z., Chen, L., Wang, Y., Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. The American Journal of Chinese Medicine 39:1 (2011), 15–27, 10.1142/S0192415X11008610.
77. Zaporozhets, T.S., Besednova, N.N., Kuznetsova, T.A., Zvyagintseva, T.N., Makarenkova, I.D., Kryzhanovsky, S.P., Melnikov, V.G., The prebiotic potential of polysaccharides and extracts of seaweeds. Russian Journal of Marine Biology 40:1 (2014), 1–9, 10.1134/S1063074014010106.
78. Zhang, L., Li, N., Caicedo, R., Neu, J., Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. Journal of Nutrition, 135, 2005.
79. Zhou, H., Liu, G., Huang, F., Wu, X., Yang, H., Improved production, purification and bioactivity of a polysaccharide from submerged cultured Ganoderma lucidum. Archives of Pharmacal Research 37:12 (2014), 1530–1537, 10.1007/s12272-014-0391-8.